Research In Brief

Cardiac troponin testing may be too sensitive to serve as the basis for identifying whether a myocardial infarction has occurred during or after a percutaneous coronary intervention, researchers concluded Feb. 27 in the Archives of Internal Medicine.

The team from multiple clinical sites used an ongoing registry (EVENT) of patients who receive FDA-approved stents, for whom lab...